Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
Clinical trial NCT01359943 · COMPLETED
Trial details
- NCT number
- NCT01359943
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.